Upstream Bio, Inc. (UPB)

Upstream Bio Revenue

Upstream Bio had revenue of $1.03M in the quarter ending March 31, 2026, with 82.69% growth. This brings the company's revenue in the last twelve months to $3.32M, up 44.69% year-over-year. In the year 2025, Upstream Bio had annual revenue of $2.85M with 20.42% growth.

• Revenue (ttm): $3.32M
• Revenue Growth: +44.69%
• P/S Ratio: 100.75
• Revenue / Employee: $44,293
• Employees: 75
• Market Cap: 334.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.85M	484.00K	20.42%
Dec 31, 2024	2.37M	-10.00K	-0.42%
Dec 31, 2023	2.38M	1.17M	96.37%
Dec 31, 2022	1.21M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error